Non-Invasive Screening for Cerebrovascular Disease in Down Syndrome
To investigate if non-invasive screening for cerebrovascular diseases in persons with Down syndrome is feasible with the goal of preventing stroke.
To explore the safety and treatment effect of intravenous (IV) Remodulin as add on therapy in neonates with PPHN compared to placebo.